Bless the CW. 

Not only did the network just renew one of our favorite shows, but it renewed two of our favorite shows, on top of having already renewed most of its line-up earlier this year. 

iZombie, which is currently in the middle of its third season, will return for a fourth, and The Originals, which is currently in its fourth, will return for a fifth season. 

They join Supergirl, Jane the Virgin, Crazy Ex-Girlfriend, Arrow, The Flash, Supernatural, DC's Legends of Tomorrow, Riverdale, and The 100 in the ranks of CW shows that aren't leaving us any time soon.

The Originals, iZombie

The CW

Unfortunately, newbie series No Tomorrow and Frequency will not be joining them, since both series were canceled on Monday after one season each. 

The CW also announced that it has picked up four new series for the 2017/2018 season—Dynasty, ValorBlack Lightning and Life Sentence

Dynasty is a reboot of the original 1980s series about a wealthy family and stars Grant Show and Elizabeth Gillies, while Valor is a military drama/conspiracy thriller about elite helicopter pilots starring Matt Barr and Christina Ochoa

Black Lightning stars Cress Williams as a dad and retired superhero with the power of electrokinesis who's forced to put his suit back on and join the fight when he feels that his daughters are in danger. 

Life Sentence is an hour-long dramedy that stars Lucy Hale as a young woman who lives like she's dying after being diagnosed with terminal cancer, then has to deal with the consequences when she finds out that diagnosis was wrong. 

Keep up with all the pilot pick-ups with our 2017 Upfronts Guide, and check back often for the latest news! 

iZombie airs Tuesdays at 9 p.m. and The Originals airs Fridays at 8 p.m. on the CW. 

We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences. By using the site, you consent to these cookies. For more information on cookies including how to manage your consent visit our Cookie Policy.